Post-infectious syndrome & persistent symptoms
Whether a post-acute infection syndrome is documented and the literature proportion with persistent symptoms.
Therapeutic agents by stage
Vector control, prevention, acute treatment, and post-infectious care. Only agents with published evidence are shown by default.
Prevention
| Agent | Type | Status | Mechanism / role | Source |
|---|---|---|---|---|
| Habitat modification & protective footwear | Prevention | Approved | Reduce human–snake contact | WHO snakebite strategy |
Acute phase
| Agent | Type | Status | Mechanism / role | Source |
|---|---|---|---|---|
| Species-specific antivenom | Antivenom | Approved | Immunoglobulin neutralization of venom toxins | WHO EML / standard of care |
| Supportive care (airway, fluids, antitetanus) | Supportive | Approved | Antivenom is definitive; supportive adjuncts | WHO snakebite strategy |
Post-infectious phase
| Agent | Type | Status | Mechanism / role | Source |
|---|---|---|---|---|
| CKD, amputation & pain rehabilitation | Rehabilitation | Approved | Chronic post-envenoming disability | Waiddyanatha 2022 |
Associated drug targets (Open Targets): —
Burden: IHME GBD (indicative seed unless refreshed) · Therapeutics: curated WHO EML / SOC + Open Targets pipeline · Post-infectious data: curated peer-reviewed literature · Ontology: MONDO_0018669 · Updated 2026-07-10. Associations, not a diagnostic test.
Generated by OSMF NTD Intelligence Pipeline · Open Source Medicine Foundation